Robert S. Cohen
Plus aucun poste en cours
Profil
Robert S.
Cohen served as Chief Executive Officer at Pharmavene, Inc. He also served as Chief Executive Officer at Memory Pharmaceuticals Corp.
and as President & Chief Executive Officer at Shire Laboratories, Inc. Additionally, he was a Director at NetMed, Inc. and NitroMed,.
Inc. Cohen received his undergraduate and graduate degrees from Long Island University.
Anciens postes connus de Robert S. Cohen
| Sociétés | Poste | Fin |
|---|---|---|
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | 24/04/2009 |
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | President | 01/05/2001 |
Shire Laboratories, Inc.
 Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | President | 01/06/1999 |
Pharmavene, Inc.
 Pharmavene, Inc. Pharmaceuticals: MajorHealth Technology Pharmavene, Inc. develops pharmaceutical products. The company develops drug delivery and screening technologies to produce optimal delivery of particular pharmaceutical products. Its technologies include proprietary Peptitrol systems for oral delivery of hard-to-deliver compounds, oral controlled-release and sustained-release delivery, transmucosal delivery through tissues in oral cavity and transdermal delivery. Pharmavene is headquartered in Rockville, MD. | President | - |
| NETMED, INC. | Directeur/Membre du Conseil | - |
Formation de Robert S. Cohen
| Long Island University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NETMED, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Health Technology |
Memory Pharmaceuticals Corp.
Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Shire Laboratories, Inc.
Shire Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Shire Laboratories was a specialty pharmaceutical company focused on developing products for its own portfolio and in partnership with other companies, using its technologies and development capabilities. The company products include CollaGenex, Indevus, Shire and United Therapeutics. Its key technologies are ProScreen, OptiScreen , Microtrol, Solutrol and EnSoTrol, for bioavailability enhancement and oral controlled release, and Avert for reduced-abuse potential. Shire Laboratories was headquartered in Rockville, MD. | Commercial Services |
Pharmavene, Inc.
Pharmavene, Inc. Pharmaceuticals: MajorHealth Technology Pharmavene, Inc. develops pharmaceutical products. The company develops drug delivery and screening technologies to produce optimal delivery of particular pharmaceutical products. Its technologies include proprietary Peptitrol systems for oral delivery of hard-to-deliver compounds, oral controlled-release and sustained-release delivery, transmucosal delivery through tissues in oral cavity and transdermal delivery. Pharmavene is headquartered in Rockville, MD. | Health Technology |
